gurusidhi pharmaceutical private limited
Tender Performance & Track Record
Company Overview
Tender Performance
Data for 01 April 2024 to 18 June 2025
Total Bids / Contract Value
Qualified Bids / Q Rate
Total Wins / Win Value
Wins Rate / Q-W Rate
Detailed Performance Analysis
Top Bid Competitors
Companies that frequently compete with you in the same tenders — ranked by their total win value.You applied for 1 bids — SSR MEDIAID SYSTEMS PRIVATE LIMITED appeared in 1 of them.
GURUSIDHI PHARMACEUTICAL PRIVATE LIMITED
GURUSIDHI PHARMACEUTICAL PRIVATE LIMITED
Financial Details
Registered Office
R1-511/1/1,Vyankat NagarLatur-Latur-Maharashtra-413512-India
Industry Classification
SCIENTIFIC RESEARCH AND DEVELOPMENT
Company Type
Market Information
Transform Your Tender Process
Join thousands of businesses winning more tenders
Smart Alerts
Get AI-powered tender recommendations
Market Intel
Track competitor bidding patterns
Email Reports
Weekly detailed analytics reports
Download Hub
Export tender data in bulk format
Smart Tracking
Never miss important deadlines
& Much More...
Discover all premium features with your trial
"TenderAI transformed our bidding process. We've increased our win rate by 40% and saved countless hours."
Historical Performance
7-year trend analysis (2018-2025)
Company Overview (1 Apr 2018-31 Mar 2025))
Total Bids
3
Contract Value
₹30.70 Lakh
L1 Bids
1
Recent Win Rate
0.0%
Performance Analytics
Gurusidhi Pharmaceutical Private Limited: Government Tender Performance Analysis
Gurusidhi Pharmaceutical Private Limited has initiated its engagement in the Indian government tender landscape, demonstrating a 33.3% win rate across 3 bids submitted between May 2023 and March 2024. This analysis provides a comprehensive review of their tender performance, financial metrics, and strategic positioning within the government procurement sector, specifically focusing on Indian government procurement opportunities and dynamics.
Executive Summary
Gurusidhi Pharmaceutical is actively participating in government tenders with an initial focus on medical supplies and equipment. Between May 2023 and March 2024, the company participated in 3 tenders, achieving a 33.3% win rate and a 66.7% qualification rate. The total contract value secured during this period amounts to ₹30.7 lakhs. The company's financial health, assessed using TenderAI scoring, is currently rated as 'Concerning' with a score of 44.8/100, reflecting a need for improvement in contract value and consistency.
The company's market positioning is primarily within the medical supplies sector, with notable engagement with the Ministry of Home Affairs, particularly the Central Armed Police Forces, and the Medical Education and Drugs Department Maharashtra. Gurusidhi Pharmaceutical has demonstrated an ability to meet technical compliance standards, achieving a qualification rate of 66.7%, but faces competition from established players like TIRUPATI ENTERPRISES and CIS MEDICAL SOLUTIONS.
The analysis highlights opportunities for Gurusidhi Pharmaceutical to enhance its bid strategy, improve its financial performance, and expand its market presence within the Indian government procurement landscape. Key focus areas include optimizing bid pricing, targeting high-value contracts, and strengthening relationships with key government departments.
Financial Performance Analysis
Gurusidhi Pharmaceutical's financial performance in government tenders reveals initial success followed by a need for strategic adjustments. The following sections detail the yearly trends, quarterly patterns, and bid distribution observed in their tender activities.